Michael P. Silvon
Director/Board Member at Chronic Airway Therapeutics
Profile
Michael P.
Silvon is currently a Director at Chronic Airway Therapeutics.
Previously, he held the position of Vice President-Planning & Development at Inotiv, Inc. He was also the General Manager at BAS Evansville, Inc. from 2000 to 2002.
Additionally, he served as Vice President-Sales & Marketing at Hi-Port, Inc. and as Regional Business Manager-Americas-Fine Chemicals at Zeneca, Inc. Silvon received his undergraduate degree from Loyola University of Chicago, his MBA from Sacred Heart University, Inc., and his doctorate from the University of Vermont.
Michael P. Silvon active positions
| Companies | Position | Start |
|---|---|---|
Chronic Airway Therapeutics
 Chronic Airway Therapeutics BiotechnologyHealth Technology Chronic Airway Therapeutics develops treatments for chronic respiratory diseases. The private company is based in Kew East, Australia. The CEO of the Australian company is Mitchell Glass. | Director/Board Member | - |
Former positions of Michael P. Silvon
| Companies | Position | End |
|---|---|---|
| BAS Evansville, Inc. | Corporate Officer/Principal | 01/01/2002 |
| Zeneca, Inc. | Corporate Officer/Principal | - |
| Hi-Port, Inc. | Sales & Marketing | - |
| INOTIV, INC. | Corporate Officer/Principal | - |
Training of Michael P. Silvon
| Loyola University of Chicago | Undergraduate Degree |
| Sacred Heart University, Inc. | Masters Business Admin |
| University of Vermont | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| INOTIV, INC. | Commercial Services |
| Private companies | 4 |
|---|---|
| BAS Evansville, Inc. | |
| Hi-Port, Inc. | |
| Zeneca, Inc. | |
Chronic Airway Therapeutics
Chronic Airway Therapeutics BiotechnologyHealth Technology Chronic Airway Therapeutics develops treatments for chronic respiratory diseases. The private company is based in Kew East, Australia. The CEO of the Australian company is Mitchell Glass. | Health Technology |
- Stock Market
- Insiders
- Michael P. Silvon
